Best Disease Self Management Companies in Zurich, Switzerland
The 40 best Disease Self Management companies in Zurich, Switzerland in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Liom.
Our analysis of 50 Disease Self Management companies
$3.0b in tracked funding; 94% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
Ranked: Best Disease Self Management companies in Zurich
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Liom Platform offering non invasive glucose monitoring solutions | $74M | 8 mo ago | Series A | Leo Grunstein Co-Founder & CEO | 2017 | WordPressApple iCloud MailMicrosoft 365+14 | — | — |
| 2 | Ava Provider of a wearable fertility tracking device | $43M | 99 mo ago | Acquired | — | 2014 | RubyRuby on RailsEnvoy+18 | 35 patents Patents concentrated in health & consumer products | — |
| 3 | Spiden Manufacturer of medical indicators | $40M | 31 mo ago | Series B | Leo Grunstein Co-Founder & CEO | 2017 | — | 14 patents Advanced time‑resolved Raman/elastic spectroscopy and low‑SNR optical detection using interferometry and avalanche photodiodes | — |
| 4 | Bloom Diagnostics Real-time health analysis devices for individuals | $22M | 72 mo ago | Series B | Tom Kupper Co-Founder and CPO | 2018 | WordPressMySQLPHP+16 | 8 patents AMH immunoassay devices and antibody-based diagnostic kits for hormone testing | — |
| 5 | Nanoleq Provider of smart textiles for remote health monitoring | $14M | 56 mo ago | Acquired | Vincent Martinez CEO and Co-Founder | 2017 | — | 21 patents Patents concentrated in electrical & electronics | — |
| 6 | Sleepiz Provider of an AI-based sleep monitoring device for patients and physicians | $9M | 53 mo ago | Series A | Max Sieghold Co-Founder & CFO | 2017 | — | — | 1 job opening |
| 7 | CARU care Provider of emergency communication system through smart alarm systems | $3M | 74 mo ago | Series A | — | 2017 | PageFlyCart FunctionalityShopify+17 | — | — |
| 8 | Connectome Provider of brain scans mapping the human brains neural connections | $2M | 5 mo ago | Seed | Rufus Mitchell-Heggs Co-Founder | 2024 | — | — | — |
| 9 | evismo Digital health diagnosis tool for healthcare providers | $1M | 59 mo ago | Seed | Willemien Van Den Toorn Founder & Co-CEO | 2018 | BackdropOdooCart Functionality+14 | — | 1 job opening |
| 10 | Sanovation Pain logbook which enables users to track pain & generates recommendations using AI | $385K | 153 mo ago | Public | Daniel Lawniczak CEO | 2011 | — | — | — |
| 11 | Resmonics Provider of AI-based respiratory diseases monitoring system | $163K | 62 mo ago | Seed | Peter Tinschert Co-Founder & CEO | 2020 | — | — | — |
| 12 | Mynerva Provider of an AI supported device to treat diabetic neuropathy | $113K | 33 mo ago | Funding Raised | Greta Preatoni Co-Founder & CEO | 2023 | — | — | — |
Top 12 Disease Self Management companies in Zurich
#1
Series A · Pfaffikon, Zurich · founded 2017$74.3Mraised▾
Platform offering non invasive glucose monitoring solutions. The company's glucose monitoring technology, seamlessly integrated with health metrics, to deliver a revolutionary wearable experience. It enables individuals to enhance managing the health and wellness through real-time data analysis. It aims to transform the way people monitor and manage the health with a focus on digital health and biotech.
- Dec 2025Series A$16.3M
- Dec 2024Series A$25M
- Jan 2024Series A$15M
- Apr 2021Series A$18M
#2
Seed · Zurich, Zurich · founded 2024$2.1Mraised▾
Provider of brain scans mapping the human brains neural connections. It aims to create personalized insights and solutions to enhace brain health by leveraging brain scans. It provides analyzes attention networks, cognitive load, and working memory, offering actionable insights for enhancing mental capabilities.
- Apr 2026Grant (prize money)$120K
- Apr 2026Seed$2M
#3
Series B · Zurich, Zurich · founded 2017 · 49 employees$40Mraised▾
Developer of medical products designed to improve the well-being of human life. The company's product uses state-of-the-art detection techniques to monitor vital medical indicators, benchmark platform for longevity, and preventative medicine by providing real-time biomarker and drug analysis to empower clinicians, enabling healthcare professionals to provide patients with a safe and healthy life.
#4
Acquired · Zurich, Zurich · founded 2014 · 3 employees$42.6Mraised▾
Provider of a wearable fertility tracking device. It provides a smart bracelet that keeps tracking the ovulation cycle and continuously monitors various body parameters. The platform uses proprietary algorithms which detect exactly where an individual is in her cycle, and hence precisely predict the day of ovulation and most fertile days. The Ava fertility tracker also gives feedback on an individual's sleep and heart rate and monitors cycle health. It needs to be synchronized with the Ava app for getting insights.
- May 2018Series B$30M
- Nov 2016Series A$9.7M
- Nov 2015Seed$2.6M
- Sep 2015Seed$133.7K
#5
Acquired · Zurich, Zurich · founded 2017 · 46 employees$13.6Mraised▾
Provider of smart textiles for remote health monitoring. It offers medical wear that allows doctors to precisely monitor vital signs and health in clothes with the mission is to decentralize the healthcare system and provide everyone with the tools to monitor their own health.
- Dec 2021Series A$12.5M
- Jan 2019Seed$1.1M
- Aug 2018Grant (prize money)$57.9K
- Feb 2018Grant (prize money)$62.5K
#6
Series A · Zurich, Zurich · founded 2017$8.5Mraised▾
Provider of an AI-based sleep monitoring device for patients and physicians. The platform provides patient-centric disease management and sleep monitoring solutions through the seamless integration of contactless monitoring. The remote monitoring device assists with the measurement of vital signals and diagnoses sleeping disorders. The wireless millimeter wave technology, sensor fusion, and artificial intelligence measure movements originating from heart contractions and breathing patterns.
- Mar 2022Series A$1.9M
- Nov 2021Series A$1.1M
- Aug 2021Series A$4.8M
- May 2021Seed$500K
#7
Series B · Zurich, Zurich · founded 2018 · 68 employees$22Mraised▾
Real-time health analysis devices for individuals. The company has developed a medical self-assessment device and software that has the ability to measure blood markers for generating a personalized health report for users. It has features for capturing data, recording information on an app, and real-time data processing.
- Aug 2020Series B$11.7M
- May 2019Series A$5.6M
#8
Series A · Zürich, Zurich · founded 2017 · 26 employees$3.2Mraised▾
Developer of sensors designed to offer real-time monitoring and an emergency call system. The company's sensors interact with its users, alert them to irregularities and share relevant information with trusted individuals in everyday life and emergency situations, enabling the elderly, their families and caretakers to connect efficiently in the time of emergency, increasing safety and well-being in the process.
- Jul 2020Series A$3.2M
- Feb 2019Seed—
#9
Seed · Zurich, Zurich · founded 2018 · 9 employees$1.1Mraised▾
Digital health diagnosis tool for healthcare providers. The company has developed products with the ability to monitor and diagnose cardiac arrhythmias. It has features to suspect abnormalities, ECG monitoring, data security, and more.
- Sep 2021Seed$1.1M
#10
Funding Raised · Zurich, Zurich · founded 2023$113.2Kraised▾
Provider of an AI supported device to treat diabetic neuropathy. It provides neurostimulating solution to eliminate chronic pain and restore sensation in individuals with diabetic neuropathy. It aims to enhance the life for patients suffering from the condition by providing a non invasive and effective treatment option.
- Nov 2023Grant (prize money)$113.2K
- Sep 2023Grant (prize money)—
#11
Seed · Zurich, Zurich · founded 2020 · 9 employees$163.2Kraised▾
Provider of AI-based respiratory diseases monitoring system. The platform has developed an asthma warning system using deep learning technology on clinically validated biomarkers. The smartphone app monitors the symptoms automatically and passively at night. The notifications are sent in case of a medical emergency to the patients.
- Jun 2021Seed$163.2K
- Jan 2021Seed—
- Nov 2020Seed—
#12
Public · Zurich, Zurich · founded 2011 · 5 employees$385Kraised▾
Sanovation develops software to help chronic pain patients. Their product, CatchMyPain App, is a pain tracker and community app. It is a digital logbook provides a structured and visual way to describe the pain area. They are planning to work on gaining empirical insights about the most probable diagnoses and the most promising treatments for each specific pain pattern. Claims to have 45k+ patients using their community app. It is a digital logbook provides a structured and visual way to describe the pain. It uses machine learning algorithms identify clusters of similar patients based on the diaries. This allows pain sufferers to learn from others who have the same problem in a personalized pain community app.
- Nov 2013Angel$385K
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Disease Self Management coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
How research on Digital Health in Zurich is moving
A read on the academic research around Digital Health in Zurich — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 152 papers.
- University of Zurich74
- ETH Zurich65
- University Hospital of Zurich24
- ZHAW Zurich University of Applied Sciences23
- University Children\'s Hospital Zurich5
- Interoperability5
- Software4
- Health data4
- Data sharing4
- Set (abstract data type)3
- Health informatics1→4
- Health care1→25
- Health informatics2→7
- Health administration2→5
- Nursing1→3
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.